This spring we joined a Bavarian state ministry delegation to the San Francisco Bay Area. For a company built on bringing diagnostics to the patient, spending a week at the centre of global MedTech and AI was a chance to test our thinking against the places where much of it is being shaped.
The week was dense with conversations — MedTech companies, AI researchers and investors, each with a different view of where clinical technology is heading. We came to listen as much as to present, and to understand how a mobile, modular eye-diagnostics platform like SeeCure reads to people working far outside the German healthcare system.
What we take home is momentum. The interest in early detection for glaucoma and AMD, and in diagnostics that travel to the patient rather than the other way around, is clearly international. We return with new relationships, a sharper sense of where SeeCure fits, and the conviction that the problem we are solving matters well beyond Bavaria.